Form 4: Director Matthew Morris Receives Privia Health Equity Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Director Matthew Morris was granted 8,463 restricted stock units in Privia Health Group, Inc. as part of the company's 2021 Omnibus Incentive Plan.

Summary

  • Director Matthew Morris acquired 8,463 restricted stock units (RSUs) on May 20, 2026.
  • The grant was issued under the Privia Health Group, Inc. 2021 Omnibus Incentive Plan.
  • The RSUs are scheduled to vest on the earlier of the day before the 2027 annual meeting or the first anniversary of the grant date.
  • Following this transaction, the director's direct beneficial ownership increased to 76,651 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine disclosure of director compensation that does not signal a change in company strategy or financial health.

Positives

  • Alignment of director interests with shareholders through equity-based compensation.
  • Standard incentive structure utilized to retain board leadership.

Negatives

  • None identified; this is a routine equity grant disclosure.

Risks

  • Equity grants are subject to market volatility affecting the ultimate value of the compensation.

Future Outlook

The RSUs will vest in approximately one year, contingent upon the director's continued service to the company.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the healthcare technology sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

  • The grant structure is consistent with standard equity compensation practices for publicly traded healthcare companies.
  • Vesting schedules align with typical one-year cliff or annual meeting-based vesting cycles seen in the industry.

Stakeholder Impact

  • Minimal impact on shareholders as this is a standard equity incentive grant.

Next Steps

  • Vesting of the 8,463 restricted stock units in 2027.

Key Dates

DateDescription
05/20/2026Date of the restricted stock unit grant transaction.
05/22/2026Date the Form 4 was filed with the SEC.

Keywords

Privia Health, PRVA, Form 4, Insider Trading, Equity Compensation, Director Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.